OnabotulinumtoxinA
OnabotulinumtoxinA is a pharmaceutical drug with 72 clinical trials. Currently 2 active trials ongoing. Historical success rate of 87.7%.
Success Metrics
Based on 50 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
18
Mid Stage
38
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
82.0%
50 of 61 finished
18.0%
11 ended early
2
trials recruiting
72
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
Clinical Trials (72)
A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants
Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms
Botulinum Toxin and/or Greater Occipital Nerve Block for Patients With Chronic Migraine
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
Preoperative BOTOX® Injection for Large Ventral Hernia Repair
A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.
A Study To Assess the Safety of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence
A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma Prominence
Study to Demonstrate Safety and Duration of Effect of 40 Units of PrabotulinumtoxinA-xvfs to Treat Glabellar Lines
A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma Prominence
Pretreatment Botulinum Toxin in Head and Neck Cancer Surgery
A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines
A Study to Evaluate Safety and Efficacy of BOTOX in Adults With Moderate COPD
Real World Effectiveness of Eptinezumab in Participants With Migraine
Spread of PrabotulinumtoxinA-xvfs Versus OnabotulinumtoxinA in the Treatment of Forehead Rhytides
Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain Population
A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
A Phase I/II Study of Recombinant Botulinum Toxin Type A for the Treatment of Moderate to Severe Glabellar Lines
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 72